These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 2650063

  • 41. Immunosuppression of graft rejection with idarubicin-monoclonal antibody conjugates by elimination of T cell subsets in vivo.
    Smyth MJ, Pietersz GA, McKenzie IF.
    Transplantation; 1988 Jul; 46(1):126-31. PubMed ID: 2899362
    [Abstract] [Full Text] [Related]

  • 42. Donor-specific unresponsiveness to cardiac allografts in the mouse: an examination of mechanisms.
    Bushnell A, Pearson TC, Morris PJ, Wood KJ.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):726-8. PubMed ID: 1990665
    [No Abstract] [Full Text] [Related]

  • 43. An active suppressor mechanism preventing skin allograft rejection in mice.
    Kilshaw PJ, Brent L, Pinto M.
    Transplant Proc; 1975 Jun; 7(2):225-8. PubMed ID: 48301
    [No Abstract] [Full Text] [Related]

  • 44. Effects of CD4 and CD8 specific monoclonal antibodies in vitro and in vivo on T cells and their relation to the allograft response in rhesus monkeys.
    Jonker M, Nooij FJ, Steinhof G.
    Transplant Proc; 1987 Oct; 19(5):4308-14. PubMed ID: 2445065
    [No Abstract] [Full Text] [Related]

  • 45. Anti-T cell-specific immunoconjugates in mice: in vivo effects.
    Mottram PL, Smyth M, Pietersz GA, Clunie GJ, McKenzie IF.
    Transplant Proc; 1989 Oct; 21(5):3757-8. PubMed ID: 2573184
    [No Abstract] [Full Text] [Related]

  • 46. Analysis of cellular events within stable and rejecting allografts in cynomolgus monkeys.
    Wee SL, Colvin RB, Stroka DM, Jolliffe LK, Cosimi AB.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):821-3. PubMed ID: 1990702
    [No Abstract] [Full Text] [Related]

  • 47. New strategies of heparin treatment used to prolong allograft survival.
    Gorski A, Lao M, Gradowska L, Nowaczyk M, Wasik M, Lagodzinski Z.
    Transplant Proc; 1991 Aug; 23(4):2251-2. PubMed ID: 1871863
    [No Abstract] [Full Text] [Related]

  • 48. Monoclonal antibodies against intercellular adhesion molecule 1 prolong cardiac allograft survival in cynomolgus monkeys.
    Flavin T, Ivens K, Rothlein R, Faanes R, Clayberger C, Billingham M, Starnes VA.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):533-4. PubMed ID: 1671305
    [No Abstract] [Full Text] [Related]

  • 49. Suppressor cell activation by anti-thy 1.2 in NZB/WF1 mice.
    Klassen LW, Zarate A, Gelfand MC, Steinberg AD.
    J Immunol; 1977 Dec; 119(6):2067-72. PubMed ID: 334981
    [No Abstract] [Full Text] [Related]

  • 50. Basis for differing biological immunosuppressive potencies of monoclonal and polyclonal T cell antibodies.
    Sherburne CG, Condie RM, Onyekaba CO.
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1036-9. PubMed ID: 2523113
    [No Abstract] [Full Text] [Related]

  • 51. Immunosuppressive antibody treatment prolongs graft survival in two murine models of segmental pancreas transplantation.
    Purcell LJ, Mottram PL, Mandel TE.
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():349-52. PubMed ID: 8225401
    [Abstract] [Full Text] [Related]

  • 52. Immunosuppression using a monoclonal antibody to ICAM-1 in murine allotransplantation.
    Guymer RH, Mandel TE.
    Transplant Proc; 1992 Feb; 24(1):218-9. PubMed ID: 1347183
    [No Abstract] [Full Text] [Related]

  • 53. Comparison of a monoclonal anti-T cell antibody vs ATG as prophylaxis after heart transplantation.
    Wollenek G, Laufer G, Laczkovics A, Buxbaum P, Kober I.
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2499-501. PubMed ID: 2495642
    [No Abstract] [Full Text] [Related]

  • 54. Idarubicin-anti-CD3 reduces vascular disease in mouse cardiac allografts.
    Mottram PL, Han W, Murray-Segal L, Pietersz GA, McKenzie IF.
    Transplant Proc; 1999 Feb; 31(1-2):1414-5. PubMed ID: 10083624
    [No Abstract] [Full Text] [Related]

  • 55. Diagnosis and treatment of acute cardiac allograft rejection.
    Oyer PE, Stinson EB, Bieber CP, Reitz BA, Raney AA, Baumgartner WA, Shumway NE.
    Transplant Proc; 1979 Mar; 11(1):296-303. PubMed ID: 377648
    [Abstract] [Full Text] [Related]

  • 56. Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice.
    Kirkman RL, Barrett LV, Gaulton GN, Kelley VE, Ythier A, Strom TB.
    J Exp Med; 1985 Jul 01; 162(1):358-62. PubMed ID: 3925068
    [Abstract] [Full Text] [Related]

  • 57. Relationship of rabbit ATG serum clearance rate to circulating T-cell level, rejection onset, and survival in cardiac transplantation.
    Bieber CP, Griepp RB, Oyer PE, David LA, Stinson EB.
    Transplant Proc; 1977 Mar 01; 9(1):1031-6. PubMed ID: 325730
    [No Abstract] [Full Text] [Related]

  • 58. Comparison of two monoclonal antibodies affecting canine transplantation reactions.
    Carreno M, Esquenazi V, Olson L, Fuller L, Alejandro R, Milgrom M, Miller J.
    Transplant Proc; 1987 Feb 01; 19(1 Pt 1):612-4. PubMed ID: 2484197
    [No Abstract] [Full Text] [Related]

  • 59. Treatment of murine cardiac allograft by monoclonal antibodies to IL-2 receptor alpha chain and beta chain.
    Isobe M, Suzuki J, Okubo Y, Horie S, Tanaka T, Miyasaka M, Sekiguchi M.
    Transplant Proc; 1997 Jun 01; 29(4):2301-2. PubMed ID: 9193630
    [No Abstract] [Full Text] [Related]

  • 60. A model of the corneal allograft reaction.
    Duguid IG, Cuthbertson RA, Guymer RH, Williams KA, Mandel TE.
    Transplant Proc; 1990 Oct 01; 22(5):2105-6. PubMed ID: 2219309
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.